ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30837-10mg |
|
1221443-94-2 |
A-1165442
|
0 | C22H20ClF2N3O2 | |
GC30837-5mg |
|
1221443-94-2 |
A-1165442
|
0 | C22H20ClF2N3O2 | |
GC30837-1mg |
|
1221443-94-2 |
A-1165442
|
0 | C22H20ClF2N3O2 | |
GC30837-10mM(1mLinDMSO) |
|
1221443-94-2 |
A-1165442
|
0 | C22H20ClF2N3O2 | |
GC30836-100mg |
|
1227923-29-6 |
MK-7622 (M1 receptor modulator)
|
0 | C25H25N3O2 | |
GC30836-50mg |
|
1227923-29-6 |
MK-7622 (M1 receptor modulator)
|
0 | C25H25N3O2 | |
GC30836-10mg |
|
1227923-29-6 |
MK-7622 (M1 receptor modulator)
|
0 | C25H25N3O2 | |
GC30836-5mg |
|
1227923-29-6 |
MK-7622 (M1 receptor modulator)
|
0 | C25H25N3O2 | |
GC30836-10mM(1mLinDMSO) |
|
1227923-29-6 |
MK-7622 (M1 receptor modulator)
|
0 | C25H25N3O2 | |
GC30835-50mg |
|
808732-98-1 |
Rislenemdaz (MK-0657)
|
0 | C19H23FN4O2 | |
GC30835-10mg |
|
808732-98-1 |
Rislenemdaz (MK-0657)
|
0 | C19H23FN4O2 | |
GC30835-5mg |
|
808732-98-1 |
Rislenemdaz (MK-0657)
|
0 | C19H23FN4O2 | |
GC30835-1mg |
|
808732-98-1 |
Rislenemdaz (MK-0657)
|
0 | C19H23FN4O2 | |
GC30835-10mM(1mLinDMSO) |
|
808732-98-1 |
Rislenemdaz (MK-0657)
|
0 | C19H23FN4O2 | |
GC30834-100mg |
|
412950-08-4 |
Rilapladib (SB 659032)
|
0 | C40H38F5N3O3S | |
GC30834-50mg |
|
412950-08-4 |
Rilapladib (SB 659032)
|
0 | C40H38F5N3O3S | |
GC30834-25mg |
|
412950-08-4 |
Rilapladib (SB 659032)
|
0 | C40H38F5N3O3S | |
GC30834-10mg |
|
412950-08-4 |
Rilapladib (SB 659032)
|
0 | C40H38F5N3O3S | |
GC30834-5mg |
|
412950-08-4 |
Rilapladib (SB 659032)
|
0 | C40H38F5N3O3S | |
GC30834-10mM(1mLinDMSO) |
|
412950-08-4 |
Rilapladib (SB 659032)
|
0 | C40H38F5N3O3S | |